Entry |
|
Symbol |
IFNB1
|
Name |
|
KO |
|
Organism |
oga Otolemur garnettii (small-eared galago)
|
Pathway |
oga04060 | Cytokine-cytokine receptor interaction |
oga04620 | Toll-like receptor signaling pathway |
oga04621 | NOD-like receptor signaling pathway |
oga04622 | RIG-I-like receptor signaling pathway |
oga04650 | Natural killer cell mediated cytotoxicity |
oga05163 | Human cytomegalovirus infection |
oga05167 | Kaposi sarcoma-associated herpesvirus infection |
oga05168 | Herpes simplex virus 1 infection |
oga05170 | Human immunodeficiency virus 1 infection |
|
Brite |
KEGG Orthology (KO) [BR:oga00001]
09130 Environmental Information Processing
09132 Signal transduction
04630 JAK-STAT signaling pathway
100959385 (IFNB1)
04668 TNF signaling pathway
100959385 (IFNB1)
04151 PI3K-Akt signaling pathway
100959385 (IFNB1)
09133 Signaling molecules and interaction
04060 Cytokine-cytokine receptor interaction
100959385 (IFNB1)
09140 Cellular Processes
09143 Cell growth and death
04217 Necroptosis
100959385 (IFNB1)
09150 Organismal Systems
09151 Immune system
04620 Toll-like receptor signaling pathway
100959385 (IFNB1)
04621 NOD-like receptor signaling pathway
100959385 (IFNB1)
04622 RIG-I-like receptor signaling pathway
100959385 (IFNB1)
04623 Cytosolic DNA-sensing pathway
100959385 (IFNB1)
04650 Natural killer cell mediated cytotoxicity
100959385 (IFNB1)
09158 Development and regeneration
04380 Osteoclast differentiation
100959385 (IFNB1)
09160 Human Diseases
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
100959385 (IFNB1)
05161 Hepatitis B
100959385 (IFNB1)
05160 Hepatitis C
100959385 (IFNB1)
05171 Coronavirus disease - COVID-19
100959385 (IFNB1)
05164 Influenza A
100959385 (IFNB1)
05162 Measles
100959385 (IFNB1)
05168 Herpes simplex virus 1 infection
100959385 (IFNB1)
05163 Human cytomegalovirus infection
100959385 (IFNB1)
05167 Kaposi sarcoma-associated herpesvirus infection
100959385 (IFNB1)
05169 Epstein-Barr virus infection
100959385 (IFNB1)
05165 Human papillomavirus infection
100959385 (IFNB1)
09171 Infectious disease: bacterial
05135 Yersinia infection
100959385 (IFNB1)
05152 Tuberculosis
100959385 (IFNB1)
09174 Infectious disease: parasitic
05142 Chagas disease
100959385 (IFNB1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
100959385 (IFNB1)
09167 Endocrine and metabolic disease
04936 Alcoholic liver disease
100959385 (IFNB1)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:oga04052]
100959385 (IFNB1)
Cytokines and neuropeptides [BR:oga04052]
Cytokines
Interferons
100959385 (IFNB1)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
Unknown
|
AA seq |
187 aa
MTNKCILQVILLLCFLTMASSTSSSLLQFQQRRSTLGCQKLLRQLNGKPEGCLKDRMNFE
IPKEIKQPQHLQKEDAMLFIYEMLQNIFRILRRDFSSTGWNETIVDALLANFHQQMDSLE
TTLDEKLEDKNFIGGKVTNILHLKSYYFRITWYLKAKRYSSCAWTVVREEILRNLFFINR
LTGYLKN |
NT seq |
564 nt +upstreamnt +downstreamnt
atgaccaacaagtgcatcctccaagtcatcctcctgctgtgcttcctcactatggcttct
tccaccagctccagcttgcttcagttccaacagagaagaagtaccttggggtgtcagaag
ctcctgcggcaattgaatgggaagcctgaaggttgcctcaaggacaggatgaactttgag
atccctaaggagatcaagcagccacagcatctccagaaggaggacgccatgttgttcatc
tatgagatgctccagaacatcttcagaattttgagaagagatttctctagcactggctgg
aatgagaccattgtagatgctctccttgctaacttccatcagcagatggactctctggag
acaaccctggacgaaaaactagaggacaaaaacttcatcgggggaaaagtcacaaacatt
ctgcacctgaagagttattacttcaggatcacgtggtacctgaaggccaagaggtacagc
agctgtgcctggacagttgtccgagaggaaatcctcaggaacctcttcttcattaacaga
ctaacaggatacctgaaaaactga |